Skip to main content

Multimodal imaging in parkinsonisms: from the molecular synaptic pruning to the whole-brain connectomics

Project description

Imaging technology to improve diagnostic of Parkinsonism

Parkinsonism is the second most prevalent neurodegenerative disorder after Parkinson’s disease (PD), and 20 % of patients are diagnosed with atypical parkinsonisms (AP). AP tends to be therapy-resistant and presents a faster degeneration rate than PD. The EU-funded SYNPARK project is an interdisciplinary action that will investigate the value of the different imaging markers' modalities in various parkinsonism forms. Improving diagnostic accuracy is important now, when disease-modifying therapies are becoming available for PD. The research involves a multidisciplinary approach of the in vivo synaptic molecular brain assessment using positron emission tomography (PET), the whole-brain connectomics organisation using magnetic resonance imaging and the clinical validation of a new generation PET tracer in AP/PD.

Field of science

  • /medical and health sciences
  • /agricultural sciences/animal and dairy science/pets
  • /engineering and technology/medical engineering/diagnostic imaging/magnetic resonance imaging

Call for proposal

H2020-MSCA-IF-2019
See other projects for this call

Funding Scheme

MSCA-IF-GF - Global Fellowships

Coordinator

UNIVERSITAT DE BARCELONA
Address
Gran Via De Les Corts Catalanes 585
08007 Barcelona
Spain
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 232 497,60

Partners (1)

CENTRE FOR ADDICTION AND MENTAL HEALTH
Canada
Address
1001 Queen St W
M6J 1H4 Toronto
Activity type
Other